Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2021 | Developing universal CAR-T therapies for T-ALL

Jing Pan, MD, Beijing Boren Hospital, Beijing, China, comments on the next steps in the field of chimeric antigen receptor T-cell (CAR-T) therapies for T-cell acute lymphoblastic leukemia (T-ALL), highlighting the challenges surrounding the expansion and persistence of universal CAR-T cells. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.